A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: eFT508
Sponsor: Effector Therapeutics